Voorn-Brouwer T, Kragt A, Tabak H F, Distel B
Department of Biochemistry, University of Amsterdam, Academic Medical Center, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands.
J Cell Sci. 2001 Jun;114(Pt 11):2199-204. doi: 10.1242/jcs.114.11.2199.
The classic model for peroxisome biogenesis states that new peroxisomes arise by the fission of pre-existing ones and that peroxisomal matrix and membrane proteins are recruited directly from the cytosol. Recent studies challenge this model and suggest that some peroxisomal membrane proteins might traffic via the endoplasmic reticulum to peroxisomes. We have studied the trafficking in human fibroblasts of three peroxisomal membrane proteins, Pex2p, Pex3p and Pex16p, all of which have been suggested to transit the endoplasmic reticulum before arriving in peroxisomes. Here, we show that targeting of these peroxisomal membrane proteins is not affected by inhibitors of COPI and COPII that block vesicle transport in the early secretory pathway. Moreover, we have obtained no evidence for the presence of these peroxisomal membrane proteins in compartments other than peroxisomes and demonstrate that COPI and COPII inhibitors do not affect peroxisome morphology or integrity. Together, these data fail to provide any evidence for a role of the endoplasmic reticulum in peroxisome biogenesis.
过氧化物酶体生物发生的经典模型表明,新的过氧化物酶体通过已有的过氧化物酶体分裂产生,并且过氧化物酶体基质蛋白和膜蛋白直接从细胞质中募集。最近的研究对该模型提出了挑战,并表明一些过氧化物酶体膜蛋白可能通过内质网运输到过氧化物酶体。我们研究了三种过氧化物酶体膜蛋白Pex2p、Pex3p和Pex16p在人成纤维细胞中的运输,所有这些蛋白都被认为在到达过氧化物酶体之前会经过内质网。在这里,我们表明这些过氧化物酶体膜蛋白的靶向不受COPI和COPII抑制剂的影响,这些抑制剂会阻断早期分泌途径中的囊泡运输。此外,我们没有获得证据表明这些过氧化物酶体膜蛋白存在于过氧化物酶体以外的区室中,并证明COPI和COPII抑制剂不会影响过氧化物酶体的形态或完整性。总之,这些数据未能提供任何证据表明内质网在过氧化物酶体生物发生中起作用。